Burkholderia cepacia in cystic fibrosis. Variable disease course

D D Frangolias1, E Mahenthiralingam, S Rae

  • 1Pulmonary Research Laboratory, Division of Infectious and Immunological Diseases, Department of Pediatrics, Canadian HIV Trials Network, British Columbia, Vancouver.

Insights

Burkholderia cepacia (B. cepacia) colonization in cystic fibrosis (CF) patients does not always worsen lung function. However, B. cepacia is linked to increased intravenous antibiotic use and reduced long-term survival in CF patients.

Area of Science:

  • Medical Microbiology
  • Pulmonology
  • Genetics

Background:

  • Burkholderia cepacia complex (BCC) infections in cystic fibrosis (CF) patients are associated with variable clinical outcomes.
  • Previous studies suggest BCC acquisition leads to accelerated clinical deterioration.

Purpose of the Study:

  • To determine if B. cepacia acquisition impacts pulmonary disease progression in CF patients.
  • To investigate the association between B. cepacia colonization and clinical outcomes, controlling for baseline disease severity.

Main Methods:

  • Matched cohort study comparing CF patients colonized with B. cepacia to non-colonized controls.
  • Patients were matched for age, sex, BMI, FEV1, and pancreatic status.
  • Analysis of pre- and post-acquisition pulmonary function (FEV1, FVC), weight changes, and intravenous antibiotic courses.

Main Results:

  • No significant differences in annual rates of change for FEV1, FVC, or weight were observed between B. cepacia and control groups.
  • B. cepacia cases showed a significantly higher frequency of intravenous antibiotic courses.
  • Higher long-term mortality was observed in the B. cepacia cohort (p < 0.05).

Conclusions:

  • B. cepacia colonization itself may not directly worsen pulmonary status in CF.
  • The association of B. cepacia with poorer outcomes may be due to patients with more advanced disease being more susceptible to colonization.
  • Specific B. cepacia strains might possess enhanced pathogenicity, contributing to worse clinical trajectories.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...